Star Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$200M
- Investors
-
19
Star Therapeutics General Information
Description
Developer of antibody-based therapeutics designed to treat serious and underserved diseases through novel biological pathways. The company offers a pipeline-in-a-product approach with proprietary antibody platforms, enabling patients with bleeding disorders to benefit from targeted, effective, and patient-centered treatments.
Contact Information
Website
www.star-therapeutics.comCorporate Office
- 201 Haskins Way
- San Francisco, CA 94080
- United States
Corporate Office
- 201 Haskins Way
- San Francisco, CA 94080
- United States
Star Therapeutics Timeline
Star Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 23-Oct-2026 | $200M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series D) | 22-Sep-2025 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series C) | 05-Sep-2023 | $90M | $190M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC (Series A) | 16-Feb-2022 | $100M | $100M | Completed | Clinical Trials - Phase 3 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Star Therapeutics Comparisons
Industry
Financing
Details
Star Therapeutics Competitors (48)
One of Star Therapeutics’s 48 competitors is Second Genome, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Second Genome | Formerly VC-backed | Brisbane, CA | ||||
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Abcuro | Venture Capital-Backed | Newton, MA | ||||
| Perthera | Venture Capital-Backed | McLean, VA | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA |
Star Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Star Therapeutics Patents
Star Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240400677-A1 | Sirp gamma antibodies and uses thereof | Pending | 10-Nov-2021 | ||
| US-20230174648-A1 | Sirp alpha and sirp beta 1 antibodies and uses thereof | Pending | 08-May-2020 | ||
| US-12503508-B2 | Sirp alpha, sirp beta 1, and sirp gamma antibodies and uses thereof | Active | 08-May-2020 | ||
| US-20230303685-A1 | Sirp alpha, sirp beta 1, and sirp gamma antibodies and uses thereof | Active | 08-May-2020 | ||
| US-20240239888-A1 | Sirp alpha, sirp beta 1, and sirp gamma antibodies and uses thereof | Active | 08-May-2020 | C07K16/2803 |
Star Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Star Therapeutics Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| Blue Owl Credit Income Corp. BDC | Lender/Debt Provider | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| GordonMD Global Investments | PE/Buyout | Minority |
Star Therapeutics Investments (2)
Star Therapeutics’s most recent deal was a Early Stage VC with Electra Therapeutics for . The deal was made on 16-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Electra Therapeutics | 16-Feb-2022 | Early Stage VC | Drug Discovery | ||
| Vega Therapeutics | Early Stage VC | Drug Discovery |
Star Therapeutics FAQs
-
When was Star Therapeutics founded?
Star Therapeutics was founded in 2018.
-
Where is Star Therapeutics headquartered?
Star Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Star Therapeutics?
Star Therapeutics has 45 total employees.
-
What industry is Star Therapeutics in?
Star Therapeutics’s primary industry is Biotechnology.
-
Is Star Therapeutics a private or public company?
Star Therapeutics is a Private company.
-
What is Star Therapeutics’s current revenue?
The current revenue for Star Therapeutics is .
-
How much funding has Star Therapeutics raised over time?
Star Therapeutics has raised $515M.
-
Who are Star Therapeutics’s investors?
Agent Capital, Blue Owl Credit Income Corp. BDC, Catalio Capital Management, Frazier Healthcare Partners, and GordonMD Global Investments are 5 of 19 investors who have invested in Star Therapeutics.
-
Who are Star Therapeutics’s competitors?
Second Genome, Centrose, Abcuro, Perthera, and Alzheon are some of the 48 competitors of Star Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
